1. Date of occurrence: May 12, 2026 2. Company name: HMD Biomedical Inc. 3. Relationship with the Company: The Company 4. Reciprocal shareholding ratio: N/A 5. Cause of occurrence: The Board of Directors approved the 2025 annual financial statements. 6. Countermeasures: N/A 7. Other matters: None